Skip to Content



View full screen / Print PDF » Download PDF ⇩


Information for the User

* Abbreviated to APO-go® Pen in the text

PEN PIL UK-IRL-MT 002.indd 1

30/04/2015 09:37

Read all of this leaflet carefully before you
start using this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your
doctor, nurse or pharmacist.
- This medicine has been prescribed for you.
Do not give it to others. It may harm them, even
if their symptoms are the same as yours.
- If any of the side effects get serious, or if you
notice any side effects not listed in this leaflet,
please tell your doctor, nurse or pharmacist.

In this leaflet:

What APO-go Pen is and what it is used for
Before you use APO-go Pen
How to use APO-go Pen
Possible side effects
How to store APO-go Pen
Further information

1. What APO-go Pen is and what it is used for
APO-go Pen contains apomorphine solution
for injection. It is injected into the area under
the skin (subcutaneously). The active ingredient
in APO-go Pen is apomorphine hydrochloride.
There is 10mg of apomorphine in each millilitre
of solution.

PEN PIL UK-IRL-MT 002.indd 2

30/04/2015 09:37

– if your Parkinson’s disease causes certain
mental problems such as hallucinations
and confusion
– if you are elderly or frail.

Apomorphine hydrochloride belongs to a group
of medicines known as dopamine agonists.
APO-go Pen is used to treat Parkinson’s disease.
Apomorphine helps to reduce the amount of time
spent in an “off” or immobile state in people who
have been previously treated for Parkinson’s
disease with levodopa and/or other dopamine
agonists. Your doctor or nurse will help you to
recognise the signs of when to use your medicine.
Despite the name, apomorphine does not
contain morphine.

Tell your doctor if you or your family/carer
notices that you are developing urges or cravings
to behave in ways that are unusual for you and
you cannot resist the impulse, drive or temptation
to carry out certain activities that could harm
yourself or others. These are called impulse
control disorders and can include behaviours
such as addictive gambling, excessive eating
or spending, an abnormally high sex drive or
an increase in sexual thoughts or feelings.
Your doctor may need to adjust or stop your dose.

2. Before you use APO-go Pen
Do not use APO-go Pen:

– if you are under 18 years of age
– if you have breathing difficulties
– if you have dementia or Alzheimer’s disease
– if you suffer from a mental illness with
symptoms such as hallucinations, delusions,
disordered thoughts, loss of contact with reality
– if you have liver problems
– if you have severe dyskinesia (involuntary
movements) or severe dystonia (inability to
move) despite taking levodopa
– if you are allergic to apomorphine or any of
the other ingredients of APO-go Pen (for other
ingredients, see section 6)
– if you or someone in your family are known to
have an abnormality of electrocardiogram (ECG)
called “long QT syndrome”. Tell your doctor.

Check with your doctor or pharmacist before
taking your medicine if: You are using medicines
that are known to affect the way your heart beats.
This includes medicines used for heart rhythm
problems (such as quinidine and amiodarone),
for depression (including tricyclic antidepressants
such as amitriptyline and imipramine) and for
bacterial infections (‘macrolide’ antibiotics such
as erythromycin, azithromycin and clarithromycin)
and domperidone.

Taking other medicines
If you use APO-go Pen with other medicines
the effect of those medicines may be altered.
This is particularly true for:
– Medicines such as clozapine to treat
mental disorders
– Medicines to lower your blood pressure
– Other medicines for Parkinson’s disease.

Take special care with APO-go Pen
Please inform your doctor, nurse or pharmacist:
– if you have kidney problems
– if you have lung problems
– if you have heart problems
– if you have low blood pressure or feel faint
or dizzy when you stand
– if you are taking any medicines to treat high
blood pressure
– if you feel sick or suffer from being sick

Your doctor will tell you if you need to change
the dose of your apomorphine or any of your
other medicines.
If you are taking levodopa (another medicine
for Parkinson’s disease) as well as apomorphine
your doctor should check your blood regularly.

PEN PIL UK-IRL-MT 002.indd 3

30/04/2015 09:37

If you experience these side effects, immediately
go to the nearest hospital casualty department.
APO-go Pen contains less than 1 mmol (23mg)
of sodium per 10ml, i.e. essentially sodium free.

Please tell your doctor or pharmacist if you are
taking or have recently taken any other medicine,
including medicines obtained without a prescription.

Taking APO-go with food and drink
Food and drink do not affect the way APO-go Pen
will work.

3. How to use APO-go Pen
Always use APO-go Pen exactly as your doctor
has told you. You should check with your doctor,
nurse or pharmacist if you are not sure.

Pregnancy and breast-feeding
APO-go Pen should not be used during pregnancy
unless clearly necessary. Check with your doctor
or nurse before using APO-go Pen if you are
pregnant, think you may be pregnant or you
are planning to become pregnant.

Domperidone should be taken at least 2 days
before APO-go Pen is started to stop you feeling
or being sick.

It is not known whether APO-go Pen is transferred
to breast milk. Talk to your doctor if you are
breast-feeding or intend to breast-feed.
Your doctor will explain to you, whether you
should continue/discontinue breast-feeding
or continue/discontinue taking this medicine.

Do not use APO-go Pen if:

Ask your doctor or pharmacist for advice before
taking any medicine.

(subcutaneously) as shown by your doctor
or nurse.
• Do not inject APO-go Pen into a vein.

– The solution has turned green
– The solution is cloudy or you can see
particles in it.

Where to inject APO-go Pen
• Inject APO-go Pen into an area under the skin

Driving and using machines
APO-go Pen can cause drowsiness and a strong
desire to sleep. Do not drive or use any tools or
machinery if APO-go Pen affects you in this way.

How much to use
The amount of APO-go Pen you should use and
how often to use it will depend upon your personal
needs. Your doctor will discuss this with you and
tell you how much of your medicine to use. The
amount that will work best for you will have been
determined on your visit to the specialist clinic.
– The usual daily dose is between 3mg and 30mg
– You may need as much as 100mg per day
– Typically you will need between 1 and 10
injections per day
– Each single injection should not be more than

This medicine can affect your ability to drive.
Do not drive whilst taking this medicine until you
know how this medicine affects you. It may be
an offence to drive if your ability to drive safely is
affected. There is further information for patients
who are intending to drive in Great Britain – go to

Information about the ingredients of
APO-go Pen
APO-go Pen contains sodium bisulphite which
rarely can cause a severe allergic reaction with
symptoms such as rash or itchy skin, difficulty
breathing, puffiness of the eyelids, face or lips,
swelling or redness of the tongue.

PEN PIL UK-IRL-MT 002.indd 4

Before using APO-go Pen, study the diagram below
and your Pen to familiarise yourself with your medicine.

30/04/2015 09:37

1) Dosage dial

Instructions for Use
7) Arrow showing
the dosage selected

8) Numbers indicating
the dose per injection

9) Graduations (in mg) on
the cartridge showing
total amount of
apomorphine in the Pen.
4) Membrane

3) Outer sleeve of Pen

10) Needle

6) Needle
*This pack does NOT contain
needles for use with your Pen.
Use pen needles not more than
12mm (1⁄2”) in length and not
finer than 0.33mm (29G).
Pen needles recommended
for use with insulin pens are
compatible with APO-go® Pen.

PEN PIL UK-IRL-MT 002.indd 5

2) Needle in sealed unit*
10) needle
6) needle protector
5) protective cone

30/04/2015 09:37

(f) Screw the cone (see 2) clockwise onto the
membrane until it is tight. This securely
attaches the needle.

How to use your APO-go Pen
Read these instructions carefully
IMPORTANT: Do not pull the red capped
dosage dial (see 1) before you have set the
dosage (see “Selecting the correct dose”).

(g)  emove the protective cone
(see 5), but do not throw
it away. Do not remove the
needle protector (see 6)
at this stage.

Attaching the needle
(a) Before using APO-go Pen you will need
some surgical wipes and one needle in
its protective cone (see 2).

(h) Replace the pen’s outer sleeve (see 3).

(b) Take the Pen out of its box and remove
the outer sleeve (see 3).

Selecting the correct dose
(i) Press the red capped
dosage dial (see 1) and
whilst holding it down,
turn the dial clockwise
until the arrow points to
the dose your doctor
chose for you (see 7 & 8).
Release the downward
pressure on the red capped dial. The dose
is now set and you do not need to redial for
subsequent injections.

(c) Wipe the membrane
of the Pen (see 4)
with a surgical wipe.

(d) Peel off the paper from
the needle cone (see 2).

Important: If you pass your prescribed dose
while turning the dial, just continue pressing
and turning in the same direction until the
arrow points to the dose your doctor chose
for you. Never pull and turn the red capped
dosage dial at the same time.

If your dose is 1mg, start by emptying a 1mg
dose onto a paper tissue and discarding it.
This is called ‘priming’ and is important because
it ensures you get a full dose the first time you
use your Pen. Then, set the dose you require
for injection and inject it in the usual way (see
“Injecting”). If the first dose required is more
than 1mg, you do not need to prime the Pen.

(e) It is important to bring the needle to the Pen
in a straight line, as shown above. This will
attach the needle securely. If the needle is
presented at an angle it may cause the Pen
to leak.


PEN PIL UK-IRL-MT 002.indd 6

30/04/2015 09:37


Preparing for the next injection

(j) Once you have set the dose,
gently pull out the red capped
dosage dial as far as it will go.

(q) Remove the outer sleeve of the Pen and check
there is enough apomorphine left in the cartridge
for your next injection. If there is, put a new
needle in place in the same way as before.

Check the red scale on the
plunger (see 9) and inject only
if the line that is just visible
matches the intended dose.

(r) If there is not enough apomorphine left for
another injection, prepare another Pen.
(s) Finally, replace the outer sleeve of your Pen.

(k) Using a surgical wipe, clean the area of skin
where you plan to inject the medicine and
around it.
(l) Remove the Pen’s outer sleeve
(see 3).

If you use more APO-go Pen than
you should
− Tell your doctor or contact your nearest
hospital emergency department immediately

Remove the needle protector
(see 6).
(n) Insert the needle (see 10)
into the skin as shown by
your doctor.

− You may experience a slow heart rate,
excessive sickness, excessive sleepiness
and/or difficulty breathing. You may also feel
faint or dizzy particularly when you stand up,
due to low blood pressure. Lying down and
raising your feet will help you feel better.

(o) To inject, press the red capped dosage dial
(see 1) down as far as it will go, using your
thumb if possible. Once the red capped dosage
dial is fully depressed, count to three before
withdrawing the needle.

If you forget to use APO-go Pen
Use it when you next require it. Do not use a
double dose to make up for a forgotten dose.

(p) Replace the protective cone (see 5) onto the used
needle and push gently into place. Once secure,
turn the needle anti-clockwise to unscrew it.

If you stop using APO-go Pen
Do not stop using APO-go Pen without first
talking with your doctor.

Keep the needle in its protective cone and
discard it in a safe place, such as a “Sharps” bin
or an empty coffee jar.

If you have any further questions on the use of this
medicine, ask your doctor, nurse or pharmacist.


PEN PIL UK-IRL-MT 002.indd 7

30/04/2015 09:37

• Breathing difficulties
• Injection site ulceration
• Reduction in red blood cells which can make
the skin pale yellow and cause weakness
or breathlessness
• Reduction in blood platelets, which increases
the risk of bleeding or bruising

4. Possible side effects
Like all medicines, APO-go Pen can cause side
effects, although not everybody gets them.
If you experience an allergic reaction stop taking
APO-go Pen and contact a doctor or your nearest
hospital emergency department immediately.
The signs of an allergic reaction may include:
• Rash
• Breathing difficulties
• Swelling of the face, lips, throat or tongue

Rare side effects (affect less than
1 in 1000 people)
• An allergic reaction
• Eosinophilia, an abnormally high amount
of white blood cells in the blood or in
body tissues.

APO-go Pen may sometimes cause the following:

Very common side effects (affect more than
1 in 10 people)
• Lumps under the skin at the site of injection

Side effects occurring in an unknown
number of users:

which are sore, troublesome and may be red
and itchy. In order to avoid getting these lumps,
it is advisable to change the site of
injection every time you insert the needle.

• Swelling of the legs, feet or fingers
• Inability to resist the impulse, drive or temptation
to perform an action that could be harmful to you
or others, which may include:
m Strong impulse to gamble excessively despite
serious personal or family consequences.
m Altered or increased sexual interest and
behaviour of significant concern to you or to
others, for example, an increased sexual drive.
m Uncontrollable excessive shopping or spending.
m Binge eating (eating large amounts of food in
a short time period) or compulsive eating
(eating more food than normal and more
than is needed to satisfy your hunger).

Common side effects (affect less than
1 in 10 people)
• Feeling sick or being sick, particularly when
starting APO-go Pen. If you are taking
domperidone and still feel sick, or if you are
not taking domperidone and you feel sick,
tell your doctor or nurse as soon as possible
• Feeling tired or extremely sleepy
• Confusion or hallucinations
• Yawning
• Feeling dizzy or light-headed when standing up.

Tell your doctor if you experience any of these
behaviours; she or he will discuss ways of
managing or reducing the symptoms.

Uncommon side effects (affect less than
1 in 100 people)

Reporting of side effects

• Increased involuntary movements or increased
shakiness during ‘on’ periods
• Haemolytic anaemia, an abnormal breakdown of
red blood cells in the blood vessels or elsewhere
in the body. This is an uncommon side effect
that can occur in patients also taking levodopa
• Suddenly falling asleep
• Rashes

If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. You can also
report side effects directly via:
United Kingdom
Yellow Card Scheme

PEN PIL UK-IRL-MT 002.indd 8

30/04/2015 09:37

HPRA Pharmacovigilance, Earlsfort Terrace
IRL - Dublin 2
Tel: +353 1 6764971, Fax: +353 1 6762517
ADR Reporting

hydrochloride. Each millilitre of APO-go Pen
contains 10mg of apomorphine hydrochloride. Each
APO-go Pen contains 3ml of solution for injection.

By reporting side effects you can help provide
more information on the safety of this medicine.

What APO-go Pen looks like

Each APO-go Pen also contains:
− Sodium bisulphite (E222)
− Hydrochloric acid (37%)
− Water for Injections.
Refer to ‘Section 2: Information about the ingredients
of APO-go Pen’ regarding sodium bisulphite.
APO-go Pen is a disposable multiple dose Pen
injector system with a clear glass cartridge
containing the apomorphine solution for injection.
The solution is clear, practically colourless,
odourless and free from visible particles.

5. How to store APO-go Pen
Keep out of the reach and sight of children.
Do not store above 25°C. Keep the container in
the outer carton to protect from light. Store at
the same conditions after opening and between

Contents of the pack
Packs contain 1, 5 or 10 pens in a moulded
plastic tray in an outer cardboard carton.
Not all pack sizes may be marketed.

Do not use APO-go Pen after the expiry date stated
on the carton and label. The expiry date refers to
the last day of that month.

Marketing Authorisation Holder
and Manufacturer

When you start using a new APO-go Pen, it can
be used for up to 48 hours. Do not re-use your
APO-go Pen after this time. Use a new Pen.

Britannia Pharmaceuticals Ltd.
200 Longwater Avenue, Green Park, Reading
Berkshire RG2 6GP, UK

To dispose of your Pens safely, always remove
the needle from the Pen before discarding it in a
“Sharps” bin or other suitable container such as
an empty coffee jar.

Laboratoire Aguettant
1 Rue Alexander Fleming, Boite Postale 7144
69353 Lyon, Cedex 07, France
STADA Arzneimittel AG
Stadastraße 2-18, 61118 Bad Vilbel, Germany

When your “Sharps” bin or container is full,
please give it to your doctor or pharmacist for
safe disposal. If the Pen is completely empty you
may dispose of it in your household waste. If the
Pen contains some apomorphine, please return it
to your pharmacist.

Distributor in the UK
Britannia Pharmaceuticals Ltd.
200 Longwater Avenue, Green Park, Reading
Berkshire RG2 6GP, UK

6. Further information

Distributor in Ireland

What APO-go Pen contains

Clonmel Healthcare Ltd., Waterford Road
Clonmel, County Tipperary, Ireland

The active substance is apomorphine

PEN PIL UK-IRL-MT 002.indd 9

30/04/2015 09:37

This medicinal product is authorised in the
Member States of the EEA under the
following names:






APO-go Στυλεοφόρος συσκευή
10 mg/ml Ενέσιμο Διάλυμα

APO-go PEN 10 mg/ml
Solución inyectable


Apogo PEN 10 mg/ml
injektioneste, liuos

APO-go 10 mg/ml raztopina
za injiciranje v peresniku


APO-go 10 mg/ml
süstelahus pen-süstlis



APO-go PEN 10 mg/ml
injektionsvæske, opløsning


APO-go 10 mg/ml soluţie
injecţabilă în pen multidoză

Slovak Republic: APO-go 10 mg/ml injekčný

roztok naplnený v pere

Czech Republic: BRITAJECT PEN 10 mg/ml

Injekční Roztok

APO-go Pen 10 mg/ml
Solução injectável


АПО-го® ПИСАЛКА 10mg/ml
Инжекционен разтвор

APO-go PEN, 10 mg/ml,
roztwór do wstrzykiwań


APO-GO®-PEN 10 mg/ml
oplossing voor injectie

Britaject 10mg/ml
oppløsning i ferdigfylt penn


Austria, Germany: APO-go PEN 10 mg/ml


APO-go PEN Oplossing
voor injectie 10 mg/ml

APO-go PEN 10 mg/ml
injektionsvätska, lösning

Greece: APO-go Στυλεοφόρος συσκευή
10 mg/ml Ενέσιμο Διάλυμα
Britaject Pen 10mg/ml
oldatos injekció

APO-go PEN 10 mg/ml
stungulyf, lausn

Ireland, Malta,

APO-go Pen 10mg/ml
Solution for Injection


APO-go PEN 10 mg/ml
šķīdums injekcijām

Britaject 10 mg/ml
injekcinis tirpalas

APO-go® PEN 10 mg/ml
Solution Injectable

This leaflet was last revised in
April 2015.

PEN PIL UK-IRL-MT 002.indd 10

30/04/2015 09:37

If this leaflet is difficult to see or
read and you would like it in a
different format, please contact
Britannia Pharmaceuticals Ltd.


PEN PIL UK-IRL-MT 002.indd 11

UK-IRL-MT 018 / 9243356 XXXX

30/04/2015 09:37

PEN PIL UK-IRL-MT 002.indd 12

30/04/2015 09:37

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.